 | |  | |  | |  | |  | |  | |  | |  |
| Technology for Life |
| References |
|
The Latest Publication
He PA, Nie Z, Chen J, Chen J, Lv Z, Sheng Q, Zhou S, Gao X, Kong L, Wu X, Jin Y, Zhang Y. (2008).
Identification and characteristics of microRNAs from Bombyx mori. BMC Genomics 9(1), 248.
Small RNA Discovery
Lee I, Ajay SS, Chen H, Maruyama A, Wang N, McInnis MG, Athey BD (2008)
Discriminating single-base difference miRNA expressions using microarray Probe Design Guru (ProDeG). Nucleic Acids Res 36(5), e27.
Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad, O, Bentwich Z, Szafranska AE, et al. (2006).
The colorectal microRNAome. Proc Natl Acad Sci U S A 103, 3687-3692.
Cancer Research
Kort EJ, Farber L, Tretiakova M, Petillo D, Furge KA, Yang XJ, Cornelius A, Teh BT (2008).
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.Cancer Res 68(11),4034-8.
Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J. (2008).
Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175), 147-52. [abstract]
Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R. (2008)
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7(3), 464-73.
Lin SL, Chiang A, Chang D, Ying SY. (2008).
Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14(3), 417-24.
Yoshida N, Amanai M, Fukui T, Kajikawa E, Brahmajosyula M, Iwahori A, Nakano Y, Shoji S, Diebold J, Hessel H, Huss R, Perry AC. (2007).
Broad, ectopic expression of the sperm protein PLCZ1 induces parthenogenesis and ovarian tumours in mice. Development & Disease 134(21),3941-52.
Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E, Slack FJ. (2007).
MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67(23), 11111-6. [abstract]
Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. (2007).
High mobility group A2 is a target for miRNA-98 in Head and Neck Squamous Cell Carcinoma. Mol Cancer 6(1), 5.
Pogribny IP, Tryndyak VP, Boyko A, Rodriguez-Juarez R, Beland FA, Kovalchuk O. (2007).
Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat Res 619(1-2), 30-7.
Koturbash I, Boyko A, Rodriguez-Juarez R, McDonald R, Tryndyak V, Kovalchuk I, Pogribny I, Kovalchuk O. (2007).
Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis 28(8), 1831-38.
Shah YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez FJ. (2007).
PPAR{alpha} regulates an miRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol Cell Biol 27(12), 4238-47.
Kovalchuk O, Tryndyak VP, Montgomery B, Boyko A, Kutanzi K, Zemp F, Warbritton AR, Latendresse JR, Kovalchuk I, Beland FA, Pogribny IP. (2007).
Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression. Cell Cycle
6(16), 2010-8.
Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA. (2006).
Specific activation of microRNA-127 with downregulation of the protooncogene BCL6 by chromatin-modifying drugs in human
cancer cells. Cancer Cell 9(6), 435-443.
1 2 Next
He PA, Nie Z, Chen J, Chen J, Lv Z, Sheng Q, Zhou S, Gao X, Kong L, Wu X, Jin Y, Zhang Y. (2008).
Identification and characteristics of microRNAs from Bombyx mori. BMC Genomics 9(1), 248.
Small RNA Discovery
Lee I, Ajay SS, Chen H, Maruyama A, Wang N, McInnis MG, Athey BD (2008)
Discriminating single-base difference miRNA expressions using microarray Probe Design Guru (ProDeG). Nucleic Acids Res 36(5), e27.
Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad, O, Bentwich Z, Szafranska AE, et al. (2006).
The colorectal microRNAome. Proc Natl Acad Sci U S A 103, 3687-3692.
Cancer Research
Kort EJ, Farber L, Tretiakova M, Petillo D, Furge KA, Yang XJ, Cornelius A, Teh BT (2008).
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.Cancer Res 68(11),4034-8.
Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J. (2008).
Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175), 147-52. [abstract]
Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R. (2008)
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7(3), 464-73.
Lin SL, Chiang A, Chang D, Ying SY. (2008).
Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14(3), 417-24.
Yoshida N, Amanai M, Fukui T, Kajikawa E, Brahmajosyula M, Iwahori A, Nakano Y, Shoji S, Diebold J, Hessel H, Huss R, Perry AC. (2007).
Broad, ectopic expression of the sperm protein PLCZ1 induces parthenogenesis and ovarian tumours in mice. Development & Disease 134(21),3941-52.
Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E, Slack FJ. (2007).
MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67(23), 11111-6. [abstract]
Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. (2007).
High mobility group A2 is a target for miRNA-98 in Head and Neck Squamous Cell Carcinoma. Mol Cancer 6(1), 5.
Pogribny IP, Tryndyak VP, Boyko A, Rodriguez-Juarez R, Beland FA, Kovalchuk O. (2007).
Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat Res 619(1-2), 30-7.
Koturbash I, Boyko A, Rodriguez-Juarez R, McDonald R, Tryndyak V, Kovalchuk I, Pogribny I, Kovalchuk O. (2007).
Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis 28(8), 1831-38.
Shah YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez FJ. (2007).
PPAR{alpha} regulates an miRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol Cell Biol 27(12), 4238-47.
Kovalchuk O, Tryndyak VP, Montgomery B, Boyko A, Kutanzi K, Zemp F, Warbritton AR, Latendresse JR, Kovalchuk I, Beland FA, Pogribny IP. (2007).
Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression. Cell Cycle
6(16), 2010-8.
Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA. (2006).
Specific activation of microRNA-127 with downregulation of the protooncogene BCL6 by chromatin-modifying drugs in human
cancer cells. Cancer Cell 9(6), 435-443.
1 2 Next
| @ 2008 Copyright GenxBio-All rights reserved Terms of use |
|
|
